Naeimzadeh F, Sadeghi A, Saghaleini S, Sarbakhsh P, Mahmoodpoor A, Gharekhani A
Bioimpacts. 2025; 15:30261.
PMID: 39963575
PMC: 11830133.
DOI: 10.34172/bi.2024.30261.
Golinelli S, Fracassi F, Bianchi E, Poppl A, Miceli D, Benedicenti L
J Vet Intern Med. 2023; 37(2):578-585.
PMID: 36798032
PMC: 10061197.
DOI: 10.1111/jvim.16620.
Morgans H, Chadha V, Warady B
Pediatr Nephrol. 2021; 36(8):2545-2551.
PMID: 34143302
DOI: 10.1007/s00467-021-05101-z.
Nagata N, Yuki M
Can Vet J. 2015; 56(9):931-3.
PMID: 26347041
PMC: 4535507.
Iwamoto J, Honda A, Miyamoto Y, Miyazaki T, Murakami M, Saito Y
J Clin Biochem Nutr. 2014; 55(3):221-7.
PMID: 25411530
PMC: 4227833.
DOI: 10.3164/jcbn.14-77.
Creatine, L-carnitine, and ω3 polyunsaturated fatty acid supplementation from healthy to diseased skeletal muscle.
DAntona G, Nabavi S, Micheletti P, Di Lorenzo A, Aquilani R, Nisoli E
Biomed Res Int. 2014; 2014:613890.
PMID: 25243159
PMC: 4163371.
DOI: 10.1155/2014/613890.
Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.
Reuter S, Evans A
Clin Pharmacokinet. 2012; 51(9):553-72.
PMID: 22804748
DOI: 10.1007/BF03261931.
Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques.
Wikoff W, Pendyala G, Siuzdak G, Fox H
J Clin Invest. 2008; 118(7):2661-9.
PMID: 18521184
PMC: 2398736.
DOI: 10.1172/JCI34138.
Pharmacokinetics of L-carnitine.
Evans A, Fornasini G
Clin Pharmacokinet. 2003; 42(11):941-67.
PMID: 12908852
DOI: 10.2165/00003088-200342110-00002.
Slow replenishment of carnitine deficiency after cessation of long-term treatment with pivaloyl-containing antibiotics.
Diep Q, Bohmer T, Holme J, TORVIK A, Storrosten O, Loennecken C
Pharm World Sci. 1993; 15(5):225-9.
PMID: 8257960
DOI: 10.1007/BF01880631.
No effect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients.
Pregant P, Kaiser E, Schernthaner G
Clin Investig. 1993; 71(8):610-2.
PMID: 8219654
DOI: 10.1007/BF00184484.
EMG changes in chronically dialyzed uraemic subjects undergoing d, 1-Carnitine treatment.
Rossini P, Marchionno L, Gambi D, Pirchio M, Del Rosso G, Albertazzi A
Ital J Neurol Sci. 1981; 2(3):255-62.
PMID: 7341547
DOI: 10.1007/BF02335405.
Plasma and urine free L-carnitine in human diabetes mellitus.
De Palo E, Gatti R, Sicolo N, Padovan D, Vettor R, Federspil G
Acta Diabetol Lat. 1981; 18(1):91-5.
PMID: 7211090
DOI: 10.1007/BF02056110.
Effect of inhibition of fatty acid oxidation on neonatal liver carnitine content.
Frost S, Wells M
Biochem J. 1982; 204(3):861-3.
PMID: 7126171
PMC: 1158431.
DOI: 10.1042/bj2040861.
[Carnitine deficiency: a treatable cause of cardiomyopathy in children (author's transl)].
Regitz V, Hodach R, Shug A
Klin Wochenschr. 1982; 60(8):393-400.
PMID: 7098383
DOI: 10.1007/BF01735930.
Parenteral nutrition: current status and concepts.
Phillips G, Odgers C
Drugs. 1982; 23(4):276-323.
PMID: 6806063
DOI: 10.2165/00003495-198223040-00003.
N6-Trimethyl-lysine metabolism. 3-Hydroxy-N6-trimethyl-lysine and carnitine biosynthesis.
Hoppel C, Cox R, Novak R
Biochem J. 1980; 188(2):509-19.
PMID: 6772168
PMC: 1161895.
DOI: 10.1042/bj1880509.
Carnitine in human nutrition.
Bach A
Z Ernahrungswiss. 1982; 21(4):257-65.
PMID: 6758382
DOI: 10.1007/BF02020743.
[Serum levels and urine excretion of L-carnitine in patients with normal and impaired kidney function].
Leschke M, Rumpf K, Eisenhauer T, Becker K, Bock U, Scheler F
Klin Wochenschr. 1984; 62(6):274-7.
PMID: 6716912
DOI: 10.1007/BF01721888.
Potential role of carnitine in patients with renal insufficiency.
Wanner C, Horl W
Klin Wochenschr. 1986; 64(13):579-86.
PMID: 3091903
DOI: 10.1007/BF01735259.
